Back to Treatments

Treatment

Mineralocorticoid Receptor Antagonists (e.g., Spironolactone)

1
Conditions
1
Trials
15K
Participants
65%
Average Safety

Condition Evidence

Dilated Cardiomyopathy

1 trials · 15K participants

85% effectiveness · 65% safety
Mineralocorticoid Receptor Antagonists (e.g., Spironolactone) | DFDA